These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1676 related items for PubMed ID: 35256934
21. Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Dahlhoff C, Worsch S, Sailer M, Hummel BA, Fiamoncini J, Uebel K, Obeid R, Scherling C, Geisel J, Bader BL, Daniel H. Mol Metab; 2014 Aug; 3(5):565-80. PubMed ID: 25061561 [Abstract] [Full Text] [Related]
28. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1. Wu D, Yang Y, Hou Y, Zhao Z, Liang N, Yuan P, Yang T, Xing J, Li J. Cancer Commun (Lond); 2022 Jan 15; 42(1):37-55. PubMed ID: 34981667 [Abstract] [Full Text] [Related]
29. Therapeutic regulation of autophagy in hepatic metabolism. Byrnes K, Blessinger S, Bailey NT, Scaife R, Liu G, Khambu B. Acta Pharm Sin B; 2022 Jan 15; 12(1):33-49. PubMed ID: 35127371 [Abstract] [Full Text] [Related]
30. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells. Huang C, Deng W, Xu HZ, Zhou C, Zhang F, Chen J, Bao Q, Zhou X, Liu M, Li J, Liu C. Comput Struct Biotechnol J; 2023 Jan 15; 21():1606-1620. PubMed ID: 36874158 [Abstract] [Full Text] [Related]
32. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats. Ge CX, Yu R, Xu MX, Li PQ, Fan CY, Li JM, Kong LD. Eur J Pharmacol; 2016 Jan 05; 770():154-64. PubMed ID: 26593707 [Abstract] [Full Text] [Related]
33. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Schröder T, Kucharczyk D, Bär F, Pagel R, Derer S, Jendrek ST, Sünderhauf A, Brethack AK, Hirose M, Möller S, Künstner A, Bischof J, Weyers I, Heeren J, Koczan D, Schmid SM, Divanovic S, Giles DA, Adamski J, Fellermann K, Lehnert H, Köhl J, Ibrahim S, Sina C. Mol Metab; 2016 Apr 05; 5(4):283-295. PubMed ID: 27069868 [Abstract] [Full Text] [Related]
34. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH. World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001 [Abstract] [Full Text] [Related]